SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-14-132190
Filing Date
2014-04-07
Accepted
2014-04-04 20:52:33
Documents
10

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d702724ds3.htm S-3 348063
2 EX-4.10 d702724dex410.htm EX-4.10 285206
3 EX-4.12 d702724dex412.htm EX-4.12 97518
4 EX-4.13 d702724dex413.htm EX-4.13 98939
5 EX-4.14 d702724dex414.htm EX-4.14 88756
6 EX-5.1 d702724dex51.htm EX-5.1 25397
7 EX-12.1 d702724dex121.htm EX-12.1 20864
8 EX-23.1 d702724dex231.htm EX-23.1 1808
9 GRAPHIC g702724001.jpg GRAPHIC 13235
10 GRAPHIC g702724g48b75.jpg GRAPHIC 6455
  Complete submission text file 0001193125-14-132190.txt   994973
Mailing Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080 650 474 8200
THRESHOLD PHARMACEUTICALS INC (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-195084 | Film No.: 14747183
SIC: 2834 Pharmaceutical Preparations